Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UnitedHealth Pursuing Payer/Pharma Collaboration To Evaluate Novel Cancer Treatments

Executive Summary

Four drug manufacturers, three payers and one genetics company are close to launching a pilot that provides pharma companies “an environment where they can supply those early testable drugs to patients anywhere with the right set of complex system biology,” UnitedHealthcare Senior VP Lee Newcomer said.


Related Content

Lung Cancer “Master Protocol” Eyed As Paradigm-Changing Approach To Drug Development
The Next Phase In Oncology: FDA’s Pazdur Has New Vision For Drug Development
Cancer Pathways Will Help Inform Drug Performance Measures, Payers Say


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts